NRIX (Nurix Therapeutics, Inc.) is set to announce its Q2'26 results on July 09, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 15.29 million USD with EPS (earnings per share) anticipated at (0.72) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported44.06 M7.89 M13.58 M6.25 M— | Revenue Estimate17.55 M16.05 M13.40 M14.25 M15.29 M | Revenue Surprise+151.08%-50.80%+1.33%-56.13% | EPS Reported(0.52)(1.03)(0.82)(0.79) | EPS Estimate(0.72)(0.82)(0.87)(0.76)(0.72) | EPS Surprise+27.65%-26.01%+5.85%-3.60% |